Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2002-11-01
2010-10-12
Jiang, Shaojia Anna (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S120000, C514S646000, C514S733000
Reexamination Certificate
active
07811996
ABSTRACT:
The invention provides compositions and methods for reducing one or more symptoms of an autoimmune disease, inflammatory disease, and/or transplant rejection, by the administration to a subject in need thereof a pharmaceutically effective amount of a purified compound of any one of Formulae A-E. The invention's methods are useful for the prevention, amelioration, and treatment of autoimmune disease, inflammatory disease, and/or transplant rejection.
REFERENCES:
patent: 5500367 (1996-03-01), Hain et al.
patent: WO 99/01148 (1999-01-01), None
patent: WO 99/59561 (1999-11-01), None
patent: WO 99/59561 (1999-12-01), None
patent: WO 02/32410 (2002-01-01), None
patent: WO 02/05825 (2002-04-01), None
Holzheimer, J. Chemotherapy, 2001, 13(1), 159-172.
Tsai et al, Proc. Natl. Sci. Counc., 1999, 23(3), 99-106.
Lin et al, British J. Pharmacology, 1999, 126, 673-680.
Aoki, “A study of endotoxemia in ulcerative colitis and Crohn's disease. I. Clinical Study,” Acta Med Okayama, 32:147-58 (1978) abstract only.
Atreya et al. “Blockade of interleukin6 transsignaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo,” Nat Med 6:583-8 (2000).
Bavaresco et al., “Stilbene compounds: from the grapevine to wine,” Drugs Exp Clin Res 25:57-63 (1999) abstract only.
Davidson et al., “T helper cell 1-type CD4+T cells, but not B cells, mediate colitis in interleukin 10-deficient mice,” J Exp Med 184:241-51 (1996).
Decker et al., “Interactions of α- and γ-interferon in the transcriptional regulation of the gene encoding a guanylate-binding protein,” EMBO J 8:2009-2014 (1989).
Dustin et al., “Induction by IL 1 and interferon-γ: Tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1),” J Immunol 137:245-54 (1986).
Geahlen et al., “Piceatannol (3,4,3′,5′-tetrahydroxy-trans-stilbene) is a naturally occurring protein-tyrosine kinase inhibitor,” BBRC, 165:241-5 (1989).
Goldberg et al., “Direct injection gas chromatographic mass spectrometric assay fortrans-resveratrol,” Anal Chem 66:3959-63 (1994).
Grimm et al., “Evidence for a CD14+population of monocytes in inflammatory bowel disease mucosa—implications for pathogenesis,” Clin Exp Immunol 100:291-7 (1995).
Groux et al., “A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis,” Nature 389:737-42 (1997).
Hassel et al., “A dominant negative mutant of 2-5 A-dependent Rnase suppresses aintiproliferative and antiviral effects of interferon,” EMBO 12:3297-3304 (1993).
Jeandet et al., “The production of resveratrol (3,5,4′-trihydroxystilbene) by grape berries in different developmental stages,” Am J Enol Vitic, 42:41-6 (1991).
Jong et al., “Development of chronic colitis in dependent on the cytokine MIF,” Nature Immunology 2:1061-1066 (2001).
Kageura et al., “Inhibitors from Rhubarb on lipopolysaccharide-induced nitric oxide production in macrophages: structural requirements of stilbenes for the activity,” Bioorg Med Chem 9:1887-93 (2001).
Karaghiosoff et al., “Partial impairment of cytokine responses in Tyk2-deficient mice,” Immunity 13:549-60 (2000).
Katze et al., “Functional expression and RNA binding analysis of the inferon-induced, double-stranded RNA-activated, 68,000-M, protein kinase in a cell-free system,” Mol Cell Biol, 11:5497-5505 (1991).
Kawachi et al., “E-selection expression in a murine model of chronic colitis,” BBRC, 268:547-52 (2000).
Ko et al., “Anti-platelet aggregation activity of stilbene derivatives fromRheum undulatum,” Arch Pharm Res, 22:401-3 (1999) abstract only.
Kopp et al., “The Toll-receptor family and control of innate immunity,” Curr Opin Immunol, 11:13-8 (1999).
Kucharzik et al., “Circulating antiinflammatory cytokine II-10 in patients with inflammatory bowel disease (IBD),” Clin Exp Immunol 100:452-6 (1995).
Lafaille et al., “High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice,” Cell 78:399-408 (1994).
Langcake et al., “The production of resveratrol byVitis viniferaand other members of the vitaceae as a response to infection and injury,” Physiol Plant Pathol, 9:77-86 (1976) not provided at this time.
Larner et al., “Transcriptional induction of two genes in human cells by β interferon,” Proc Natl Acad Sci USA 81:6733-6737 (1984).
Levy et al., “Interferon-stimulated transcription: Isolation of an inducible gene and identification of its regulatory region,” Proc Natl Acad Sci USA 83:8929-8933 (1986).
Lin et al., “Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteosome-mediated degradation,” Mol Cell Biol 18:2986-96 (1998).
Loh et al., “Dissection of the interferon-γ MHC class II signal transduction pathway reveals that type I and type II interferon systems share common signaling component(s),” EMBO 11:1351-1363 (1992).
Luster et al., “Genomic characterization of a gamma-interferon-inducible gene (IP-10) and identification of an interferon-inducible hypersensitive site,” Mol Cell Biol 7:3723-3731 (1987).
Madsen et al., “Inflammatory bowel disease: Lessons from theIL-10gene-deficient mouse,” Clin Invest Med 24:250-7 (2001).
Marotta et al., “Induction of LFA-I/CD11a and ICAM-1/CD54 adhesion molecules on neoplastic B cells during in vivo treatment of chronic lymphocytic leukemia with interferon-α2,” Blood 81:267-9 (1993).
Moreno-Manas et al., “Dehydroacetic acid chemistry. A new synthesis of resveratrol, a phytoalexin ofVitis vinifera,” Anal Quim 81:157-161 (1985) not provided at this time.
Murakami et al., “Effect of stilbene derivatives on gastric H+, K+-ATPase,” Biochem Pharmacol 44:1947-51 (1992).
Navarro et al., “Cytomegalovirus activates interferon immediate-early response gene expression and an interferon regulatory factor 3-containing interferon-stimulated response element-binding complex,” Mol Cell Biol, 18:3796-3802 (1998).
Navarro and David, “p38-dependent activation of interferon regulatory factor 3 by lipopolysaccharide,” J Biol Chem 274:35535-8 (1999).
Neurath et al., “Antibodies to Interleukin 12 Abrogate Established Experimental Colitis in Mice,” J Exp Med 182:1281-90 (1995).
Palmieri et al., “Effect of resveratrol and some other natural compounds on tyrosine kinase activity and on cytolysis,” Drugs Exp Clin Res 25:79-85 (1999) abstract only.
Porter et al., “Interferon response element of the human gene 6-16,” EMBO J 7:85-92 (1988).
Raventos et al., “Direct HPLC analysis ofcis- andtrans-resveratrol and piceid isomers in Spanish redVitis viniferawines,” J Agric Food Chem, 43:281-283 (1995).
Reich et al., “Interferon-induced transcription of a gene encoding a 15-kDa protein depends on an upstream enhancer element,” Proc Natl Acad Sci USA 84:6394-6398 (1987).
Schreiber et al., “Immunoregulatory role of interleukin-10 in patients with inflammatory bowel disease,” Gastroenterology 108:1434-44 (1995).
Sevransky et al., “Tyrphostin AG556 improves survival and reduces multiorgan failure in canineEscherichi coliperitonitis,” J Clin Invest 99:1966-1973 (1997).
Su and David, “Distinct mechanisms of STAT phosphorylation via the interferon-α/β receptor,” J Biol Chem 275:12661-6 (2000).
Thakkar et al., Synthesis and protein-tyrosine kinase inhibitory activity of polyhydroxylated stilbene analogues of piceatannol, J Med Chem, 36:2950-5 (1993).
van Dullemen et al., “Treatment of
Jiang Shaojia Anna
Krishnan Ganapathy
Medlen & Carroll LLP
The Regents of the University of California
LandOfFree
Methods and compositions for prevention and treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for prevention and treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for prevention and treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4151635